Iterum Therapeutics

NASDAQ: ITRM · Real-Time Price · USD
0.86
0.04 (4.88%)
At close: Aug 15, 2025, 3:59 PM
0.86
-0.10%
After-hours: Aug 15, 2025, 05:39 PM EDT

Iterum Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-24.77M -38.37M -44.43M -91.56M
Depreciation & Amortization
284K 1.75M 1.8M 2.1M
Stock-Based Compensation
363K 784K 4.76M 4.32M
Other Working Capital
-7.99M 540K 416K -503K
Other Non-Cash Items
10.09M -6.26M 17.09M 8.14M
Deferred Income Tax
n/a n/a n/a 61.6M
Change in Working Capital
-12.73M 2.76M 2.31M -440K
Operating Cash Flow
-26.77M -39.33M -18.47M -15.84M
Capital Expenditures
-2K -13K -62K -61K
Cash Acquisitions
n/a n/a -14.02K 54.53K
Purchase of Investments
-12.39M -41.18M -45.71M -67.03M
Sales Maturities Of Investments
30.6M 64.53M 59.73M 12.5M
Other Investing Acitivies
n/a n/a 14.02K -54.53K
Investing Cash Flow
18.21M 23.34M 13.96M -54.59M
Debt Repayment
n/a n/a -2.25M -6.52M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 433K n/a
Financial Cash Flow
26.69M 1.03M -1.82M 83.13M
Net Cash Flow
18.05M -15.02M -6.38M 12.69M
Free Cash Flow
-26.77M -39.34M -18.54M -15.9M